Algal protein

Other Names

Algae proteinAlgae protein hydrolysateAlgae-based proteinAlgae-derived peptidesAlgae-derived proteinAlgal biomass proteinAlgal hydrolysateAlgal peptidesAlgal protein concentrateAlgal protein isolateBioactive peptides from algaeBlue-green algae proteinChlorella proteinCyanobacterial proteinFreshwater algae proteinGreen algae proteinMacroalgae proteinMacroalgal proteinMarine algae proteinMicroalgae proteinMicroalgae protein isolateMicroalgal proteinPhotosynthetic microorganism proteinPhycobiliproteinPhycobiliproteinsRed algae proteinSeaweed proteinSeaweed protein isolateSingle-cell protein (algal)Spirulina proteinWhole algal protein

Synopsis

Algal Protein

1. Identity: Botanical and Chemical Names, Natural Sources, and Forms

Algal protein is the collective term for protein derived from algae — a diverse group of photosynthetic, primarily aquatic organisms that encompass microalgae (single-celled, microscopic species) and macroalgae (multicellular seaweeds). The term covers proteins extracted or consumed from a wide taxonomic range, though the most commercially and nutritionally significant sources are microalgal species. Peer-reviewed studies reporting bioactive peptides and proteins derived from microalgae, macroalgae, or Cyanophyceae are most frequently represented in the scientific literature.

The principal species studied for their protein content and health relevance include:

Arthrospira platensis (commonly marketed as Spirulina): a cyanobacterium (blue-green alga), classified within the phylum Cyanobacteria. Often referred to by the synonym Spirulina platensis.
Chlorella vulgaris and related Chlorella species: green microalgae within the phylum Chlorophyta.
Nannochloropsis spp.: marine microalgae notable for their omega-3 content and protein density.
Haematococcus pluvialis (syn. Haematococcus lacustris): green microalga best known as a source of the carotenoid astaxanthin, alongside its protein fraction.
Dunaliella salina, Scenedesmus spp., and others studied in compositional analyses.

Species such as Arthrospira platensis and Chlorella vulgaris contain protein levels ranging from 50% to 70% of their dry weight, along with a well-balanced amino acid profile rich in essential amino acids such as lysine and leucine. Key species — Spirulina, Chlorella, Nannochloropsis, and Haematococcus — are highlighted for their high protein content (up to 70% dry weight), complete amino acid profiles, and rich bioactive compound content.

Common Forms and Preparations

Algal proteins and peptides are commonly marketed as powders, capsules, or tablets. Spirulina is available in powder, capsule, and tablet forms, and it is also added to certain protein bars, smoothies, and juices. Protein isolates and concentrates extracted from the algal biomass represent a more recent and technically intensive form intended for use as functional food ingredients. Efficient extraction of proteins is challenged by rigid cell walls, necessitating the development of optimized methods such as bead milling, ultrasonication, enzymatic treatments, and pulsed electric fields. These techniques preserve functionality while achieving yields of up to 96%.

2. Traditional and Historical Use

Mesoamerican Cultures: The Aztec Use of Tecuitlatl

The story of spirulina dates back to ancient times, with its first recorded use by the Aztecs and Mesoamerican cultures, who harvested spirulina from Lake Texcoco. Bernardino de Sahagún, a Franciscan missionary, documented the harvesting and cake-making processes of spirulina, known as "Tecuitlatl," in his comprehensive work on Aztec culture, Historia General de las Cosas de Nueva España. The Aztecs harvested this alga from Lake Texcoco and consumed it as a concentrated food source; historical records describe spirulina being dried into cakes and sold in marketplaces as a staple dietary item. In Mexico, spirulina was a key part of the Aztec diet, and warriors often relied on its high protein content for strength and endurance.

Sub-Saharan Africa: The Kanembu Tradition of Dihé

Spirulina was also a dietary staple in the Kanem Empire (modern-day Chad) around the 9th century. The local population harvested it from the alkaline Lake Chad and surrounding ponds, drying it into cakes called "dihé," which were later sold in markets. Communities around Lake Chad in Africa traditionally harvested spirulina and dried it into flat cakes known as "dihé," which were incorporated into soups and meals as an important protein source. In the 1940s, Belgian algae researcher Pierre Dangeard first described dihé from a scientific perspective during his travels to the Lake Chad region. In the 1960s, botanist Jean Léonard confirmed that dihé is indeed made from spirulina and is identical to the Aztec tecuitlatl.

East Asian Traditions

The consumption of algae has been prevalent among Asian populations, such as Koreans and Japanese, since ancient times; it was only in the 15th century that it was introduced into European gastronomy. Macroalgae (seaweeds such as nori, wakame, and kombu) have centuries-old culinary and medicinal traditions in East Asia, where they were consumed as dietary staples and occasionally used in traditional preparations for their purported nourishing properties.

Modern Rediscovery and Scientific Era

In the mid-20th century, scientists rediscovered spirulina and began studying its nutritional properties. In the 1970s, NASA began researching spirulina as a potential food source for astronauts on long-term space missions. The United Nations Food and Agriculture Organization (FAO) has recognized spirulina's potential in combating malnutrition and promoting sustainable food sources. Commercial production expanded substantially from the 1970s onward, with large-scale cultivation infrastructure developed first in Japan and later globally.

3. Key Constituents and Active Compounds

Protein Content and Amino Acid Profile

Microalgae proteins typically exhibit a balanced profile of essential amino acids. In species such as Spirulina platensis and Chlorella vulgaris, the essential amino acid (EAA) fraction is notable, comprising 30–50% of the total, with lysine, leucine, valine, and isoleucine being particularly abundant. Spirulina is especially rich in tryptophan, while Chlorella shows higher levels of methionine. Although the composition varies between species, common patterns emerge: glutamate and aspartate typically make up between 8% and 12% of the total. Among non-essential amino acids, tyrosine, cysteine, glycine, arginine, alanine, proline, and serine are predominant.

Microalgae proteins are nutritionally complete, containing all nine of the essential amino acids humans require. Their high digestibility and protein quality scores, such as the protein digestibility-corrected amino acid score (PDCAAS), further establish their suitability as a dietary protein source. However, actual PDCAAS values vary significantly by species and processing method: PDCAAS values for A. platensis (0.50–0.65) and C. vulgaris (0.40–0.55) have been reported, with broader ranges across species from 0.63 to 0.77. Animal proteins such as milk, egg, beef, and fish have higher PDCAAS values (0.92–1.00) than algae protein, which shows a wide range of PDCAAS (0.29–0.84).

Phycobiliproteins: Phycocyanin and Phycoerythrin

Phycocyanin, along with allophycocyanin and phycoerythrin, is a pigment-protein complex that is a member of the light-harvesting phycobiliprotein family, serving as an auxiliary pigment to chlorophyll. Unlike carotenoids, these pigments are water-soluble. Phycocyanin has documented antioxidative, anti-inflammatory, and anticancer properties, making it a promising substance in medicine and pharmaceuticals.

Bioactive Peptides

Peptides derived from microalgal proteins have been shown to possess bioactive properties, such as antioxidant, anti-inflammatory, antitumor, antimicrobial, antihypertensive, and immunostimulatory activities. Available evidence shows that algal peptides exert multifunctional bioactivities, including inhibition of angiotensin-converting enzyme (ACE) and renin, antioxidant and anti-inflammatory effects, modulation of glucose metabolism via α-amylase, α-glucosidase, and DPP-IV inhibition, and regulation of lipid metabolism and adipogenesis. Specifically, peptides derived from Spirulina platensis have demonstrated potent ACE-inhibitory activity, suggesting a mechanism for blood pressure reduction.

Co-occurring Bioactive Compounds

Beyond their macronutrient profile, microalgae are rich in bioactive compounds such as polyunsaturated fatty acids (including omega-3), vitamins (notably B12 and E), antioxidants, pigments like phycocyanin and astaxanthin, and essential minerals including iron and magnesium. Algae also contain omega-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are traditionally obtained from fish. Besides its rich protein concentration, Spirulina also includes approximately 15–25% carbohydrates and 5–8% lipids.

Amino Acid Score Compared to Reference Proteins

The amino acid scores (AAS) for C. vulgaris and C. sorokiniana were 1.10 and 1.16, respectively. The AAS values of algal protein, compared to that of casein, are high, indicating a total content of essential amino acids. However, the AAS index is not the best indicator for determining the biological quality of a protein because it does not take into account digestibility. For this purpose, the PDCAAS index was developed, which, in addition to amino acid content, also measures protein digestibility.

4. Scientific Evidence by Area of Use

4.1 Muscle Protein Synthesis and Skeletal Muscle Health

One of the most compelling aspects of algal protein is its potential to support muscle protein synthesis (MPS) and lean body mass, which is crucial for metabolic health and the prevention of age-related muscle loss.

Thirty-six healthy young adults participated in a randomized, double-blind trial in which participants ingested a drink containing 25 grams of protein from fungal-derived mycoprotein, spirulina, or chlorella. Ingestion of a single acute dose of 25 g protein from Chlorella or Spirulina resulted in postprandial increases in blood essential amino acids and robust stimulation of myofibrillar protein synthesis over a 4-hour postprandial period in both resting and exercised muscle. This degree of stimulation was comparable to that of an equivalent dose of high-quality animal-derived protein.

The University of Exeter study, published in The Journal of Nutrition, is the first of its kind to demonstrate that the ingestion of two of the most commercially available algal species supports muscle remodeling in young healthy adults. The more robust cell structure of Chlorella was noted as making the protein less bio-accessible for human digestion and/or absorption compared to Spirulina. This acute anabolic response suggests that microalgae-derived proteins could serve as a viable plant-based alternative to traditional proteins such as dairy or soy in supporting muscle remodeling and maintenance.

Evidence strength: The available clinical evidence remains heterogeneous and is largely based on small, short-term intervention studies, with substantial variability in algae species, processing methods, and dosages. Consequently, while the evidence suggests the possibility of functional effects, the strength of the evidence and its generalizability across populations remains limited.

4.2 Cardiovascular Risk Factors: Lipid Profile and Blood Pressure

The cardiovascular effects of Spirulina and Chlorella have been the subject of multiple meta-analyses of randomized controlled trials (RCTs).

Spirulina and lipid profiles: A meta-analysis revealed a significant benefit of spirulina supplementation in improving multiple markers of cardiovascular health including total cholesterol (TC), LDL-C, triglycerides (TG), VLDL-C, fasting blood glucose (FBG), and diastolic blood pressure (DBP), without any significant side effects.

Spirulina and blood pressure: A systematic review and meta-analysis showed that spirulina consumption decreases systolic blood pressure (WMD: −4.41 mmHg, 95% CI: −6.74 to −2.07) and diastolic blood pressure (WMD: −2.84 mmHg, 95% CI: −4.65 to −1.03).

Chlorella and cardiovascular risk factors: A meta-analysis on 19 RCTs with 797 subjects indicated that Chlorella administration significantly decreased total cholesterol (−9.09 mg/dL), LDL-C (−8.32 mg/dL), systolic blood pressure (−4.51 mmHg), diastolic blood pressure (−1.64 mmHg), and fasting blood glucose (−4.23 mg/dL), whereas changes in triglycerides, HDL-C, and BMI were not statistically significant.

A 2025 systematic review and meta-analysis, however, offered a more cautious interpretation: Chlorella supplementation had a neutral effect on blood pressure and lipemia. Spirulina intake led to a significant reduction in diastolic blood pressure (−0.42, 95% CI: −0.81 to −0.02, p = 0.04) but did not significantly affect lipemia indexes, despite a trend toward a reduction in total cholesterol. This meta-analysis suggests Spirulina supplementation can be used as an adjuvant to control cardiometabolic risk factors, particularly for blood pressure, but the magnitude of this effect is small and of uncertain clinical significance.

Evidence strength: Moderate. Multiple RCTs and meta-analyses exist, but study populations, dosages, durations, and algal preparations are heterogeneous, limiting firm clinical conclusions. Further randomised trials are needed to better assess the potential of these supplements as adjuvants for the control of cardiovascular risk factors.

4.3 Glycemic Control and Metabolic Health

Clinical studies from Spirulina and Chlorella trials provide evidence that algal-derived bioactives can enhance glycemic regulation, lipid metabolism, and overall metabolic health in diabetic and pre-diabetic populations. Limited human trials suggest modest but clinically relevant improvements in blood pressure, glycemic control, lipid profiles, and body-weight-related outcomes, primarily using whole algal biomass or extracts.

The mechanistic basis for glycemic effects involves peptide-level inhibition of carbohydrate-digesting enzymes. Available evidence shows that algal peptides exert multifunctional bioactivities, including modulation of glucose metabolism via α-amylase, α-glucosidase, and DPP-IV inhibition. Present amylase and glucosidase inhibitors in therapeutic use, such as acarbose, have been linked to bloating, stomach pain, diarrhea, and flatulence, creating a need for complementary approaches with fewer side effects. Nonetheless, there is a scarcity of studies on the anti-diabetic potential of microalgae amino acids, and the evidence for practical benefits of these amino acids is weak. The mechanisms behind their anti-diabetic effects have not been fully investigated.

Evidence strength: Preliminary to moderate for whole-algae products; weak to preliminary for isolated algal peptides in glycemic contexts. Most data derive from short-term RCTs in metabolically impaired populations.

4.4 Anti-Inflammatory and Antioxidant Effects

Some clinical studies employing whole algae have documented anti-inflammatory outcomes. A trial in older adults reported that supplementation with EPA-rich microalgae led to a significant decrease in IL-6 levels, indicating a reduction in systemic inflammation. Furthermore, a recent meta-analysis of randomized trials found that Spirulina intake was associated with a significant decrease in C-reactive protein (CRP), a key inflammatory marker, compared to control.

Algal proteins also contain bioactive peptides with antioxidative properties that may contribute to positive outcomes. Preclinical and limited clinical evidence indicate benefits including reductions in oxidative stress and inflammation, improved glycemic control, improved lipid profile, and modulation of immune responses.

Evidence strength: Preliminary to moderate for anti-inflammatory markers such as CRP and IL-6 in specific clinical populations; most antioxidant evidence remains in vitro or animal-based, with limited human trial data for isolated algal proteins.

4.5 Omega-3 Fatty Acid Status (EPA and DHA)

Algae contain omega-3 polyunsaturated fatty acids such as EPA and DHA, which are traditionally obtained from fish. Algal supplements can increase circulating EPA and DHA levels in omnivorous, vegetarian, and vegan populations. This property is particularly relevant for individuals who do not consume fish or fish oil products. The EPA/DHA content is associated with the broader fatty acid fraction of the algal biomass rather than the protein fraction per se, though both are co-delivered in whole-algae preparations.

Evidence strength: Well-established for bioavailability of algal-derived EPA/DHA; this area is distinct from the evidence for protein-specific effects.

4.6 Immune Function

Algae provide a broad spectrum of physiologically active nutrients, including vitamins, minerals, polyunsaturated fatty acids, antioxidant molecules, and dietary fiber. These nutrients have been linked to improved cardiovascular and metabolic health, enhanced immune function, and anti-inflammatory effects. These findings suggest that regular consumption of algal products may offer anti-inflammatory benefits in humans, potentially mediated by their bioactive protein components and associated micronutrients.

Evidence strength: Largely indirect, based on biomarker data from short-term trials; controlled clinical trials specifically examining immune endpoints with algal protein as the isolated variable are limited.

4.7 Hematological Parameters

Clinical findings have indicated substantial changes in hematological parameters, including lymphocyte levels, in response to algal supplementation. Moreover, a reduction in body fat mass, platelet count, hematocrit, and mean corpuscular hemoglobin (MCH) was observed, suggesting an overall health benefit from the supplementation.

Evidence strength: Very preliminary; individual study findings, not yet confirmed by systematic reviews.

5. Body Systems and Health Areas of Association

Musculoskeletal system: Algal proteins show amino acid compositions and digestibility comparable to other high-quality dietary proteins and may support muscle protein synthesis, metabolic regulation, immune markers, and cardiovascular risk factors under specific conditions.
Cardiovascular system: Recent clinical studies have demonstrated that the ingestion of microalgae can stimulate muscle protein synthesis and improve lipid profiles, blood pressure, and inflammation markers, indicating functional benefits beyond basic nutrition.
Metabolic/endocrine system: Glycemic regulation through enzyme inhibition and improvement of fasting blood glucose, as documented in RCT meta-analyses.
Immune system: Modulation of inflammatory markers including CRP and IL-6; potential immunostimulatory activity via phycobiliproteins.
Antioxidant defense: These compounds provide additional health benefits ranging from anti-inflammatory and antioxidant effects to cardiovascular and liver support.

6. Dosage Forms and Dosages Reported in Studies

Algal proteins and peptides are commonly marketed as powders, capsules, or tablets. The following dosages are as reported in identified clinical literature:

Spirulina — general clinical range: Clinical data are insufficient to guide therapeutic dosing of spirulina. Dosages in clinical studies have ranged from 1 to 10 g/day, usually in divided doses, given for up to 12 months.
Chlorella — cardiovascular studies: The duration of trials in a reviewed meta-analysis varied between 4 and 12 weeks, with Chlorella dosage ranging from 1,500 to 8,000 mg/day.
Spirulina and Chlorella — muscle protein synthesis study: A bolus of 25 g protein (isonitrogenous doses) from Spirulina, Chlorella, or mycoprotein was assessed for myofibrillar protein synthesis responses in resting and exercised muscle of healthy young adults.
Study duration context: The age of participants in reviewed cardiovascular trials varied from 20 to 58 years, and studies were conducted in Iran, South Korea, Japan, and Taiwan. Trial durations varied between 4 and 12 weeks.

Effects vary by species, formulation, dose, and population, and long-term clinical outcomes remain insufficiently studied.

7. Safety Considerations and Notable Interactions

General Tolerability

Algal supplements are generally well-tolerated, but some users report mild gastrointestinal symptoms, headaches, or allergic reactions. Stomach upset is one of the most commonly reported effects; gas, bloating, cramps, and loose stools often occur in the first days of use or upon sudden dose increases.

Heavy Metal and Microbial Contamination

Cadmium found in some algae exceeds legal limits. The absence of consistent regulations for algal dietary supplementation raises quality concerns and potential contamination risks during production, extraction, and processing. Because of the possible presence of mercury and other heavy metal contaminants in spirulina, use should be avoided during pregnancy. Microcystin toxins are commonly encountered in lake and marine environments as a result of algal blooms; these toxins can cause health problems.

Phenylketonuria (PKU)

Spirulina contains phenylalanine, an amino acid that individuals with phenylketonuria (PKU) cannot metabolize. Spirulina must be avoided by anyone with PKU, regardless of dose.

Autoimmune Conditions

Spirulina appears to stimulate immune activity, which may exacerbate autoimmune diseases including lupus, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease. The clinical evidence for this concern is indirect, based on immune-modulating mechanisms rather than controlled adverse event data, but caution is warranted.

Drug Interactions

Anticoagulants: Spirulina may extend bleeding time by inhibiting platelet aggregation. Additionally, vitamin K present in Chlorella may affect blood clotting, which is relevant for individuals on anticoagulant medications.

Immunosuppressants: Spirulina's immune-stimulating activity may counteract immunosuppressive drugs used in organ transplant recipients (e.g., cyclosporine, tacrolimus, mycophenolate). This interaction is based on pharmacological reasoning rather than documented clinical cases, but the potential consequence is serious enough to warrant medical oversight.

Antidiabetic medications: Spirulina may independently lower blood glucose. This creates a theoretical risk of additive blood glucose lowering when combined with insulin or oral antidiabetic agents, though this has not been definitively established in controlled clinical data.

Pregnancy and Lactation

Information regarding safety and efficacy in pregnancy and lactation is lacking. Safety summaries urge caution in pregnant and breastfeeding women because microcystin or heavy metals, even at low levels, can cause lasting damage to the developing infant.

Digestibility Limitations and Cell Wall Effects

Barriers such as structural rigidity affecting digestibility, variability in nutrient bioavailability, and technological constraints in processing continue to limit commercial utilization. For algae species with low PDCAAS, it is suggested to combine these algae with other plant-based or animal-based protein to improve the overall protein digestion.

8. Overall Evidence Assessment

Findings across the current body of clinical research suggest potential benefits for muscle protein synthesis, cardiometabolic markers, immune modulation, and antioxidant status, while emphasizing heterogeneity, short-term data, and the need for longer clinical trials. Clinical evidence supports algae as a nutrient-dense, sustainable protein source with potential health benefits beyond basic nutrition. Algal proteins show amino acid compositions and digestibility comparable to other high-quality dietary proteins and may support muscle protein synthesis, metabolic regulation, immune markers, and cardiovascular risk factors under specific conditions. Nonetheless, the available clinical evidence remains heterogeneous and is largely based on small, short-term intervention studies, with substantial variability in algae species, processing methods, and dosages. While the evidence suggests the possibility of functional effects, the strength of the evidence and its generalizability across populations remains limited.

References

Health Conditions

Health conditions that Algal protein may help support.

No conditions available.

Body Systems

Body systems that Algal protein may help support.

No body systems available.